SynthesisEndocrinology and metabolism (Seoul, Korea)2021

Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis.

Deep Dutta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.